COVID-19: Melatonin as a potential adjuvant treatment
This article summarizes the likely benefits of melatonin in the attenuation of COVID-19 based on its putative pathogenesis. The recent outbreak of COVID-19 has become a pandemic with tens of thousands of infected patients. Based on clinical features, pathology, the pathogenesis of acute respiratory...
- Autores:
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12845
- Acceso en línea:
- https://www.sciencedirect.com/science/article/pii/S0024320520303313?via%3Dihub
http://hdl.handle.net/20.500.12010/12845
https://doi.org/10.1016/j.lfs.2020.117583
- Palabra clave:
- COVID-19
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
Melatonin
Oxidation
Cytokines
Immunomodulation
Oxidation-reduction
- Rights
- License
- Acceso restringido